Stocks Industrials LMMY
OTC · IndustrialsExousia Bio, Inc. (LMMY)
Exousia Bio, Inc. brought in $0 of revenue over the twelve months to November 30, 2025, down 100.0% from a year earlier. It posted a net loss of $75.7K. At November 30, 2025 it held $0 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on June 16, 2026.
Key facts about Exousia Bio, Inc.
- Net worth
- Exousia Bio, Inc. has a market value (market cap) of $750.8K at the latest share price, and shareholders' equity of $21.8M on its balance sheet at November 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- Over the 12 months to November 30, 2025: revenue $0, net loss $75.7K.
- Cash flow
- In fiscal 2025 operations used $4.5K of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on June 16, 2026 and covers the period to February 28, 2026. Open on SEC EDGAR
What Exousia Bio, Inc. does
Exousia Bio, Inc. is registered with the SEC under industry code SIC 8200 (Services-Educational Services). Its shares trade on OTC under the ticker LMMY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.8K | $51.4K | $0.00 | n/a |
| 2024 | $11.5K | -$25.8K | $0.00 | n/a |
| 2023 | $0 | -$56.4K | $0.00 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where LMMY ranks in Industrials
Latest SEC filings
What Exousia Bio, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 31, 2026Deregistration 15-12G
- June 16, 2026Quarterly report 10-Q · period to February 28, 2026
- April 14, 2026Late quarterly report notice NT 10-Q
- March 17, 2026
- January 15, 2026Late quarterly report notice NT 10-Q
- November 17, 2025
- November 17, 2025
- October 17, 2025Annual report 10-K · period to May 31, 2025Revenue fell 67% to $3.8K versus the prior year; diluted EPS $0.00 versus $0.00.
- October 16, 2025Late quarterly report notice NT 10-Q
- August 29, 2025Late annual report notice NT 10-K
Insider trades
What the people running Exousia Bio, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about LMMY
What does Exousia Bio, Inc. do?
Exousia Bio, Inc. is a company in the Industrials sector, listed on OTC as LMMY. Its shares trade on OTC under the ticker LMMY.
What is Exousia Bio, Inc.'s net worth?
Exousia Bio, Inc. has a market value (market cap) of $750.8K at the latest share price, and shareholders' equity of $21.8M on its balance sheet at November 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Exousia Bio, Inc. profitable?
No. Over the twelve months to November 30, 2025 it reported a net loss of $75.7K.
How much revenue does Exousia Bio, Inc. make?
Over the twelve months to November 30, 2025 Exousia Bio, Inc. reported revenue of $0. That is 100.0% less than a year earlier.
When did Exousia Bio, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on June 16, 2026. It covers the period to February 28, 2026. Its newest filing of any kind is the deregistration from August 31, 2026.
Similar companies
Compare LMMY with
Follow LMMY
Get an email when Exousia Bio, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Exousia Bio, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.